Allon Therapeutics Inc. (TSX: NPC), The Neuro Protection CompanyTM, confirmed today the closing of the bought deal financing announced on May 8th, 2007. The financing was led by Blackmont Capital Inc., and included GMP Securities L.P., Cormark Securities Inc. and Versant Partners Inc. (the "underwriters"). Upon closing the "underwriters" purchased 12,500,000 units at a price of $1.20 per unit for gross proceeds to Allon Therapeutics of $15,000,000
